Case Report: Retrospective pharmacist-led multidimensional assessment in a patient with late-onset first-episode mania and elevated creatine kinase
Background Late-onset first-episode mania (LOFEM) in adults aged ≥50 years is rare and frequently complicated by cerebrovascular lesions, multimorbidity, and polypharmacy, all of which increase the risk of adverse events such as rhabdomyolysis. Differentiating agitation-related from drug-induced creatine kinase (CK) elevation in this setting is clinically challenging but critical for safe pharmacotherapy. This retrospective, post-discharge pharmacist-led multidimensional assessment explored how etiological differentiation could be achieved. Case presentation A 60-year-old woman with no prior psychiatric history presented with first-episode mania. On day 2, after a single 50 mg dose of quetiapine and an intramuscular injection of diazepam on day 1 (baseline CK was not measured), her CK was 780.9 U/L and myoglobin 112.61 ng/mL, consistent with mild biochemical rhabdomyolysis without acute kidney injury. Quetiapine was continued and titrated to 200 mg/day, combined with valproate and modified electroconvulsive therapy. CK normalized by day 21 and the patient achieved full recovery of psychiatric symptoms. Conclusions A post-discharge, retrospective multidimensional pharmaceutical assessment (Naranjo scale, Beers criteria, multi-database drug-drug interaction analysis, and geriatric dose evaluation) indicated that the overall picture was most consistent with mild biochemical rhabdomyolysis related to manic agitation and dehydration/exertion, with intramuscular diazepam as an additional confounder. Quetiapine cannot be excluded as a contributor. NMS was not clinically supported.
Authors
- Pan Zhang (ORCID: https://orcid.org/0000-0002-6739-4038)
- Junlin Diao
- Chunxiang Wei
- Haoyang Huang
Institutions
- Chongqing City Mental Health Center (CN)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fpsyt.2026.2007120
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00